GLP-1 TirzepatideRx

All-in monthly price at 10 mg — medication plus any membership fee

Home States

Tirzepatide by State

Telehealth serves all fifty states, but individual programs exclude specific ones. Check yours before you start an intake.

Written by Eduard CristeaMedically reviewed by Dr. A. Goher, MDUpdated 2026-08-05Prices verified 2026-08-05
Short answer

Compounded tirzepatide reaches patients through telehealth in most states, but coverage is program by program rather than uniform. A handful of states appear on exclusion lists repeatedly — commonly Alabama, Louisiana, Mississippi, and sometimes Arkansas, Nevada, California and the District of Columbia — because of state pharmacy rules or individual program policy.

State availability changes without notice. Treat every list, including ours, as a starting point and confirm at checkout.

By metro

Primary sources

Clinical, dosing and regulatory statements on this page rest on the documents below. Links go to the publisher, not to a summary of it. Prices are not sourced here — they carry a verification date instead, and the reason is set out in the source ledger.

  1. ZEPBOUND (tirzepatide) full prescribing information — DailyMed, US National Library of Medicine. Dose ladder, contraindications, warnings, storage.
  2. FDA’s concerns with unapproved GLP-1 drugs used for weight loss — US Food and Drug Administration. Compounded GLP-1 risks, API import alert, cold-chain complaints.
  3. FD&C Act provisions that apply to human drug compounding — US Food and Drug Administration. Why a compounded preparation is lawful without being FDA-approved.
  4. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1) — N Engl J Med 2022;387:205-216. Registration NCT04184622. The weight-reduction and adverse-event figures used across this site.
  5. The full source ledger — every primary source, what it supports, the date we read it, and the claims we deliberately do not source.